873 H&E-based Immune Phenotypes Predict Benefit from Dual Immune Checkpoint Inhibitors (ICIs) but not ICI plus Tyrosine Kinase Inhibitors (TKIs) in Metastatic Renal Cell Carcinoma (mRCC)

Read full text Summarise with VIRAT
Authors: Atsuko Seki, Hironori Fukuda, Takayuki Nakayama, Hajime Kuroda, Tsunenori Kondo, Toshio Takagi, Yoji Nagashima
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Renal cell carcinoma treatment Radiomics and Machine Learning in Medical Imaging

Publication details

Journal / source
Laboratory Investigation
Volume
106
Issue
3
Pages
105161–105161
Publication date
1 March 2026
Language
EN